Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Benjamin L Handen

Showing results (61-70 of 120) with videos related to

Pageof 12
Sort By:
Journal of the American Academy of Child and Adolescent Psychiatry|September 25, 2016
Atomoxetine and Parent Training for Children With Autism and Attention-Deficit/Hyperactivity Disorder: A 24-Week Extension StudyTristram Smith, Michael G Aman, L Eugene Arnold, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|October 11, 2025
Development and evaluation of image preprocessing pipelines for the Centiloid method on Down Syndrome dataWeiquan Luo, Davneet S Minhas, Ethan D Rubenstein, et al.
Alzheimer'S & Dementia (New York, N. Y.)|June 30, 2025
Physical activity as a resistance or resilience mechanism in Down syndrome Alzheimer's diseaseVictoria L Fleming, Jamie Peven, Brian C Helsel, et al.
The Lancet. Neurology|November 22, 2024
Timeline to symptomatic Alzheimer's disease in people with Down syndrome as assessed by amyloid-PET and tau-PET: a longitudinal cohort studyEmily K Schworer, Matthew D Zammit, Jiebiao Wang, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|January 25, 2021
Patterns of glucose hypometabolism in Down syndrome resemble sporadic Alzheimer's disease except for the putamenMatthew D Zammit, Charles M Laymon, Dana L Tudorascu, et al.
Neuroimage|January 9, 2021
PET measurement of longitudinal amyloid load identifies the earliest stages of amyloid-beta accumulation during Alzheimer's disease progression in Down syndromeMatthew D Zammit, Dana L Tudorascu, Charles M Laymon, et al.
Medrxiv : the Preprint Server for Health Sciences|August 30, 2024
Amyloid age and tau PET timeline to symptomatic Alzheimer's disease in Down syndromeEmily K Schworer, Matthew D Zammit, Jiebiao Wang, et al.
Journal of Autism and Developmental Disorders|October 26, 2013
Measuring anxiety as a treatment endpoint in youth with autism spectrum disorderLuc Lecavalier, Jeffrey J Wood, Alycia K Halladay, et al.
Autism : the International Journal of Research and Practice|November 22, 2013
Measuring repetitive behaviors as a treatment endpoint in youth with autism spectrum disorderLawrence Scahill, Michael G Aman, Luc Lecavalier, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|May 22, 2020
Amyloid accumulation in Down syndrome measured with amyloid loadMatthew D Zammit, Charles M Laymon, Tobey J Betthauser, et al.
Pageof 12

Showing results (61-70 of 120) with videos related to

Sort By:
Pageof 12
Journal of the American Academy of Child and Adolescent Psychiatry|September 25, 2016
Atomoxetine and Parent Training for Children With Autism and Attention-Deficit/Hyperactivity Disorder: A 24-Week Extension StudyTristram Smith, Michael G Aman, L Eugene Arnold, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|October 11, 2025
Development and evaluation of image preprocessing pipelines for the Centiloid method on Down Syndrome dataWeiquan Luo, Davneet S Minhas, Ethan D Rubenstein, et al.
Alzheimer'S & Dementia (New York, N. Y.)|June 30, 2025
Physical activity as a resistance or resilience mechanism in Down syndrome Alzheimer's diseaseVictoria L Fleming, Jamie Peven, Brian C Helsel, et al.
The Lancet. Neurology|November 22, 2024
Timeline to symptomatic Alzheimer's disease in people with Down syndrome as assessed by amyloid-PET and tau-PET: a longitudinal cohort studyEmily K Schworer, Matthew D Zammit, Jiebiao Wang, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|January 25, 2021
Patterns of glucose hypometabolism in Down syndrome resemble sporadic Alzheimer's disease except for the putamenMatthew D Zammit, Charles M Laymon, Dana L Tudorascu, et al.
Neuroimage|January 9, 2021
PET measurement of longitudinal amyloid load identifies the earliest stages of amyloid-beta accumulation during Alzheimer's disease progression in Down syndromeMatthew D Zammit, Dana L Tudorascu, Charles M Laymon, et al.
Medrxiv : the Preprint Server for Health Sciences|August 30, 2024
Amyloid age and tau PET timeline to symptomatic Alzheimer's disease in Down syndromeEmily K Schworer, Matthew D Zammit, Jiebiao Wang, et al.
Journal of Autism and Developmental Disorders|October 26, 2013
Measuring anxiety as a treatment endpoint in youth with autism spectrum disorderLuc Lecavalier, Jeffrey J Wood, Alycia K Halladay, et al.
Autism : the International Journal of Research and Practice|November 22, 2013
Measuring repetitive behaviors as a treatment endpoint in youth with autism spectrum disorderLawrence Scahill, Michael G Aman, Luc Lecavalier, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|May 22, 2020
Amyloid accumulation in Down syndrome measured with amyloid loadMatthew D Zammit, Charles M Laymon, Tobey J Betthauser, et al.
Pageof 12